Clopidogrel Bisulfate

CAS 120202-66-6 40 current records 18 historicalSmall Molecule

Who holds supplier records for Clopidogrel Bisulfate? 40 organisations hold a current record for Clopidogrel Bisulfate: an active US FDA Type II Drug Master File or a CEP. A further 18 organisations have only historical (inactive) DMF filings. 32 of them hold a valid EU Certificate of Suitability (34 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (27), China (8), Netherlands (1), France (1) and 1 other country (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Clopidogrel Bisulfate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/clopidogrel-bisulfate

Reading the evidence

  • 40 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    27 of the 38 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 20 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (40)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Clopidogrel Bisulfate. Country is the organisation's recorded country, not necessarily the manufacturing site.

India27China8Netherlands1France1Slovenia1Country not recorded for 2
Need Clopidogrel Bisulfate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (34)

Certificates of Suitability on the EDQM register for Clopidogrel Bisulfate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 65 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2011-152 - Rev 06
Clopidogrel hydrogen sulfate, Form I
Sept 2026—
ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. LinhaiCN
CEP 2021-414 - Rev 01
Clopidogrel hydrogen sulfate, Process C
Sept 2026—
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. ShenzhenCN
CEP 2025-547 - Rev 00
Clopidogrel hydrogen sulfate
Jul 2026—
SANOFI WINTHROP INDUSTRIE GentillyFR
CEP 2024-307 - Rev 01
Clopidogrel hydrogen sulfate
May 2026—
ZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD XianjuCN
CEP 2024-084 - Rev 02
Clopidogrel hydrogen sulfate, Process III
May 2026Inspected Sept 2024
Italy
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2021-052 - Rev 02
Clopidogrel hydrogen sulfate, Form II
May 2026—
PRAVEEN LABORATORIES PRIVATE LIMITED Jolwa VillageIN
CEP 2017-247 - Rev 02
Clopidogrel hydrogen sulfate, Process B
May 2026Inspected Nov 2025
Finland
JUBILANT BIOSYS LIMITED MysuruIN
CEP 2011-267 - Rev 02
Clopidogrel hydrogen sulfate
Mar 2026—
SYNTHIMED LABS PRIVATE LIMITED DerabassiIN
CEP 2026-032 - Rev 00
Clopidogrel hydrogen sulfate, Form II, Process 3
Mar 2026Inspected Aug 2026
Slovenia
MSN ORGANICS PRIVATE LIMITED Bibinagar VillageIN
CEP 2015-331 - Rev 01
Clopidogrel hydrogen sulfate, Form II, micronised and non-micronised
Feb 2026—
IOL CHEMICALS AND PHARMACEUTICALS LIMITED LudhianaIN
CEP 2019-006 - Rev 02
Clopidogrel hydrogen sulfate
Jan 2026—
AARTI DRUGS LIMITED MumbaiIN
CEP 2019-104 - Rev 02
Clopidogrel hydrogen sulfate
Nov 2025—
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. Dongyang CityCN
CEP 2020-165 - Rev 02
Clopidogrel hydrogen sulfate, Form II
Oct 2025—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2018-220 - Rev 05
Clopidogrel hydrogen sulfate, Form-II
Sept 2025—
APARNA PHARMACEUTICALS PRIVATE LIMITED HyderabadIN
CEP 2023-461 - Rev 00
Clopidogrel hydrogen sulfate
Aug 2025—
SCL LIFESCIENCES LIMITED Sahibzada Ajit Singh NagarIN
CEP 2022-148 - Rev 01
Clopidogrel hydrogen sulfate
Mar 2025Inspected Feb 2024
France
TAPI NL B.V. AmsterdamNL
CEP 2011-143 - Rev 04
Clopidogrel hydrogen sulfate
Mar 2025—
ARENE LIFE SCIENCES PRIVATE LIMITED HyderabadIN
CEP 2020-042 - Rev 03
Clopidogrel hydrogen sulfate
Mar 2025—
MSN LIFE SCIENCES PRIVATE LIMITED Bhiknoor VillageIN
CEP 2019-318 - Rev 01
Clopidogrel hydrogen sulfate, Form-II, milled and non-milled
Feb 2025—
SHANDONG LIXIN PHARMACEUTICAL CO. LTD. ZiboCN
CEP 2022-450 - Rev 00
Clopidogrel hydrogen sulfate
Dec 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2019-144 - Rev 03
Clopidogrel hydrogen sulfate, Form II
Sept 2024—
CHEMECA DRUGS PRIVATE LIMITED Tadi VillageIN
CEP 2021-433 - Rev 01
Clopidogrel hydrogen sulfate, Form II
Sept 2024—
METROCHEM API PRIVATE LIMITED HyderabadIN
CEP 2020-093 - Rev 01
Clopidogrel hydrogen sulfate
Jun 2024—
ZHEJIANG LEPU PHARMACEUTICAL CO., LTD Taizhou CityCN
CEP 2024-001 - Rev 00
Clopidogrel hydrogen sulfate, Process II
May 2024—
ZENJI PHARMACEUTICALS SUZHOU LTD. Xuguan, SuzhouCN
CEP 2021-230 - Rev 00
Clopidogrel hydrogen sulfate
Jan 2024—
MACLEODS PHARMACEUTICALS LIMITED MumbaiIN
CEP 2011-199 - Rev 06
Clopidogrel hydrogen sulfate
Jan 2024—
USV PRIVATE LIMITED MumbaiIN
CEP 2022-241 - Rev 00
Clopidogrel hydrogen sulfate
Dec 2023—
KRKA, d.d., Novo mesto Novo mestoSI
CEP 2014-027 - Rev 03
Clopidogrel hydrogen sulfate
Dec 2023Inspected Jul 2025
Slovenia
VASUDHA PHARMA CHEM LIMITED HyderabadIN
R0-CEP 2019-251 - Rev 01
Clopidogrel hydrogen sulfate
Feb 2023—
ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Duqiao TownCN
R1-CEP 2015-156 - Rev 00
Clopidogrel hydrogen sulfate
Jul 2021—
INNOVARE LABS PRIVATE LIMITED VisakhapatnamIN
R0-CEP 2019-338 - Rev 00
Clopidogrel hydrogen sulfate
Jul 2021—
ZHEJIANG APELOA JIAYUAN PHARMACEUTICAL CO., LTD. HengdianCN
R1-CEP 2013-162 - Rev 01
Clopidogrel hydrogen sulfate
May 2020—
MSN LABORATORIES PRIVATE LIMITED Rudraram VillageIN
R1-CEP 2011-049 - Rev 03
Clopidogrel hydrogen sulfate, Form-1
Jul 2018—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2012-030 - Rev 00
Clopidogrel hydrogen sulfate
Dec 2017—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (18)

Organisations whose Type II DMFs for Clopidogrel Bisulfate are no longer active. These show a past filing, not current supply.

Show all 18 historical records

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Clopidogrel Bisulfate is an antiplatelet agent used to reduce the risk of cardiovascular events such as heart attacks and strokes. It works by inhibiting platelet aggregation.

Chemical identity

IUPAC name
methyl (2S)-2-(2-chlorophenyl)-2-(6,7-dihydro-4H-thieno[3,2-c]pyridin-5-yl)acetate;sulfuric acid
Canonical SMILES
COC(=O)[C@H](C1=CC=CC=C1Cl)N2CCC3=C(C2)C=CS3.OS(=O)(=O)O
InChIKey
FDEODCTUSIWGLK-RSAXXLAASA-N
Synonyms
Plavix API, clopidogrel (as bisulfate), clopidogrel (as hydrogen sulfate), clopidogrel bisulphate, clopidogrel bms, clopidogrel hydrogen sulfate, clopidogrel hydrogen sulphate, clopidogrel ratiopharm, clopidogrel sulfate, clopidogrel teva, clopidogrel zentiva, clopidogrel-bgr

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
P2Y12 Platelet Inhibitor
Mechanism of action
Cytochrome P450 2C8 Inhibitors; P2Y12 Receptor Antagonists
Physiologic effect
Decreased Platelet Aggregation

Therapeutic areas

Cardiovascular DiseasesHematology

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Clopidogrel Bisulfate?

40 organisations hold an active US FDA Type II Drug Master File or a CEP for Clopidogrel Bisulfate: Zydus Lifesciences Limited (India), APITORIA PHARMA PRIVATE LTD (India), SIGNA SA DE CV, Sun Pharmaceutical Industries Limited (India), VITALIFE LABORATORIES (A DIV ARCH PHARMALABS LTD) (India), Arene Life Sciences Limited (India), CHEMECA DRUGS PRIVATE LTD (India) and Dr. Reddy's Laboratories Ltd. (India), and 32 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Clopidogrel Bisulfate Drug Master Files are active?

Zydus Lifesciences Limited (DMF 33689, 36027), APITORIA PHARMA PRIVATE LTD (DMF 19409, 33916), SIGNA SA DE CV (DMF 15721, 38695), Sun Pharmaceutical Industries Limited (DMF 21062, 30187), VITALIFE LABORATORIES (A DIV ARCH PHARMALABS LTD) (DMF 19744, 20444), Arene Life Sciences Limited (DMF 40360), CHEMECA DRUGS PRIVATE LTD (DMF 33710) and Dr. Reddy's Laboratories Ltd. (DMF 15715, 16090) and 19 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Clopidogrel Bisulfate records mean?

18 organisations have only inactive Type II DMFs for Clopidogrel Bisulfate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Clopidogrel Bisulfate have a European Certificate of Suitability?

Yes. 32 organisations hold a valid CEP for Clopidogrel Bisulfate on the EDQM register, including ZYDUS LIFESCIENCES LIMITED Vadodara (IN), ZHEJIANG LIAOYUAN PHARMACEUTICAL CO., LTD. Linhai (CN), SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD. Shenzhen (CN), SANOFI WINTHROP INDUSTRIE Gentilly (FR), ZHEJIANG CHARIOTEER PHARMACEUTICAL CO., LTD Xianju (CN) and DR. REDDY'S LABORATORIES LIMITED Hyderabad (IN) and 28 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Clopidogrel Bisulfate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Clopidogrel Bisulfate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.